BIOADAPTIVES INC
For the period ended May 20, 2024. Filed Nov 20, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 20, 2024 · Filed Nov 20, 2024
Contents
EX-99.1 · Regarding the Reverse Stock Split
Regarding the Reverse Stock Split
On November 20, 2024, BioAdaptives® announced that it will complete a 1-for-300 reverse stock split, a corresponding proportionate reduction in the number of shares of BioAdaptives® Inc.'s common stock (BDPT). BioAdaptives®shareholders previously approved the Reverse Stock Split at a special meeting on September 3, 2024. BioAdaptives®filed documents with FINRA to effectuate the reverse stock split and BioAdaptives®common stock will begin trading on a split-adjusted basis on November 21, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.